Anti-Desmin CE/IVD antibodies for immunohistochemistry (IHC) are essential reagents in soft-tissue pathology and adjunctive applications in hematopathology, enabling reliable assessment of muscle lineage differentiation in formalin-fixed, paraffin-embedded (FFPE) tissues.
Biological Significance of Desmin
Desmin is a type III intermediate filament protein predominantly expressed in smooth, skeletal, and cardiac muscle cells. It contributes to cytoskeletal organization by maintaining structural integrity and mechanical stability of muscle fibers through its role in linking Z-discs and associated cellular structures. Its expression is closely associated with myogenic differentiation, although limited expression may be observed in certain non-muscle cells such as myofibroblasts.
Diagnostic Utility of Desmin in Hematopathology
Desmin IHC is primarily used in diagnostic pathology for the evaluation of tumors with suspected myogenic differentiation, particularly in spindle cell and soft tissue lesions. It is best applied as part of a panel-based approach rather than as a standalone marker.
- Detection of muscle tumors: frequently expressed in rhabdomyomas, leiomyomas, rhabdomyosarcomas, and leiomyosarcomas.
- Specificity for muscle lineage: useful in identifying myogenic differentiation, while acknowledging potential focal expression in non-muscle cells.
- Panel integration: commonly combined with markers such as smooth muscle actin (SMA) and myogenin to improve diagnostic accuracy.
- Tumor classification: supports differentiation of myogenic tumors from fibrohistiocytic, neural, and other soft tissue neoplasms.
Key Features of Desmin CE/IVD Antibodies (IHC)
- High sensitivity for detecting muscle-associated intermediate filaments, supporting identification of myogenic differentiation.
- Validated for use on FFPE tissues with standardized antigen retrieval methods.
- Characteristic cytoplasmic staining pattern, often filamentous or striated depending on tissue context.
- Reproducible performance across IHC platforms, supporting routine diagnostic workflows.
- Compatible with multiplex and panel-based IHC strategies for comprehensive tumor characterization.
